Vous êtes ici

InnoCan Pharma Corporation

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
INNO
Indice CSE: 
Devise: 

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

Vous êtes ici

InnoCan Pharma Corporation (INNO)

SEDAR Information

Information d'entreprise

Addresse
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
Canada
Téléphone
403-777-1519
Courriel
irisb@innocanpharma.com
URL
http://innocanpharma.com
Date d’inscription à la cote
Mardi, septembre 24, 2019
Agent de transfert
Odyssey Trust Company

Advertisement

Publicité

Capitalisation

Capitalisation: 
175,342,521
Réservé à l'émission: 
22,666,583

Bulletins

Advertisement

Publicité

Latest CSE News

Évènements à venir

07-15_Virtual_Industry_Updates_Tech_Strikes_Back_Website

Virtual Industry Updates: Tech Strikes Back

Mercredi, juillet 15, 2020 -
15:00 - 16:15